Search
for
Sort by
Research 30 of 1000+
- Minoxidil topical foam: A new kid on the block
- A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women
- Effectiveness of once daily 5% minoxidil topical foam in the treatment of women with thinning hair due to female pattern hair loss (FPHL)
- Rabbit syndrome because of topical minoxidil foam
- A randomized, controlled pilot trial comparing platelet-rich plasma to topical minoxidil foam for treatment of androgenic alopecia in women
- A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men
- Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104‐week open‐label clinical trial
- A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men
- Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis
- Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction
- 5% Minoxidil topical foam for men: Hair growth in millennials – a post hoc analysis
- 5% Minoxidil topical foam on women: Menopause and other covariates
- Bracketed Stability Evaluation of Topical Minoxidil and Finasteride in Foamil®.
- An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia
- Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: A randomized comparative trial
- A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss.
- Acute Localized Exanthematous Pustulosis (ALEP) Caused by Topical Application of Minoxidil
- The effects of particle properties on nanoparticle drug retention and release in dynamic minoxidil foams
- 636 Treatment of central centrifugal cicatricial alopecia with oral minoxidil
- Manifestation of pityriasis amiantacea following initiation of minoxidil
- A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women
- Successful use of topical minoxidil in the treatment of hypotrichosis associated with desmoplakin mutations
- Comparison of a New 5% Minoxidil Foam and Rogaine® in the Treatment of Androgenetic Alopecia in Chinese Men: A Randomized, Double-Blind, Phase III, Equivalence Trial
- A Case of Contact Allergic Dermatitis to Topical Minoxidil
- The pink tax: gender-based cost disparities of topical minoxidil
- Follicular and percutaneous penetration pathways of topically applied minoxidil foam
- The ‘bald’ phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral ‘western diet’
- A Canadian Consensus on Androgenetic Alopecia: Approach and Management
- Medical Hair Restoration Brings REVVup to HairLossSpecialists
- Management of Hair Loss